2024 |
Elutia Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2024 |
Quantum-Si Incorporated - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2023 |
Elutia Inc - Ordinary Shares - Class A
|
- |
116.4 K |
-24.9 % |
2023 |
Mind Medicine Inc
|
Independent Director |
26.1 K |
-94.9 % |
2023 |
Quantum-Si Incorporated - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2022 |
Mind Medicine Inc
|
Independent Director |
511.3 K |
127.4 % |
2022 |
Quantum-Si Incorporated - Warrants (10/06/2026)
|
Independent Director |
170 K |
- |
2022 |
Quantum-Si Incorporated - Ordinary Shares - Class A
|
- |
170 K |
-28.8 % |
2022 |
Elutia Inc - Ordinary Shares - Class A
|
Independent Director |
155.1 K |
2.7 % |
2021 |
Quantum-Si Incorporated - Ordinary Shares - Class A
|
Independent Director |
238.8 K |
- |
2021 |
Mind Medicine Inc
|
Independent Director |
224.9 K |
- |
2021 |
Elutia Inc - Ordinary Shares - Class A
|
Independent Director |
151 K |
5.2 % |
2020 |
Elutia Inc - Ordinary Shares - Class A
|
Independent Director |
143.5 K |
- |
2020 |
Mind Medicine Inc
|
Director |
- |
- |
2020 |
Quantum-Si Incorporated - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2019 |
Elutia Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2001 |
Nektar Therapeutics
|
Vice President, Finance and Administration, Chief |
- |
- |